Reducing multiple pregnancy in assisted reproduction technology: towards a policy of single blastocyst transfer in younger women

BJOG. 2008 Aug;115(9):1143-50. doi: 10.1111/j.1471-0528.2008.01764.x. Epub 2008 May 30.

Abstract

Objectives: To investigate the effects of single blastocyst transfer (SBT) on live birth and multiple pregnancy in women undergoing in vitro fertilisation (IVF).

Design: Descriptive cohort study.

Setting: A London private IVF/postgraduate training unit.

Sample: A total of 700 fresh and 102 frozen blastocyst cycles performed between January 2005 and December 2006.

Methods: Young women aged 25-37 years and those aged 38-43 years were further divided into those who had SBT and those who received two blastocysts (double blastocyst transfer [DBT]). Live birth and multiple pregnancy rates were compared between groups. Cumulative live birth was compared between women who had DBT and those who received a SBT followed by a frozen blastocyst if the fresh cycle was unsuccessful.

Main outcome measures: Live birth rate, cumulative live birth rate, multiple pregnancy rate, uptake of SBT.

Results: Among women aged 25-37 years, live birth rate following SBT was 59.0 versus 60.7% following DBT. The twin pregnancy rate in this group was 2.3 and 47.6% respectively. For women aged 38-43 years, live birth following SBT was 29.4% and multiple pregnancy rate was 33.3%. DBT in older women gave a higher live birth rate (44.3%) and a multiple pregnancy rate of 36.4%. Cumulative live birth following SBT in women aged 25-37 years was 72.8% versus 60.5% following DBT. Among the women aged 38-43 years, cumulative live birth was higher (63.3%) following DBT versus 28.6% following SBT.

Conclusion: Single blastocyst transfer followed by transfer of a frozen blastocyst if the preceding fresh cycle was unsuccessful resulted in a better cumulative live birth and lower twin pregnancy in young women. In older women, two fresh blastocysts gave better results than one fresh followed by a frozen cycle. Older women should have the option of replacing two fresh blastocysts as this optimises their chances of taking home a baby.

MeSH terms

  • Adult
  • Buserelin / therapeutic use
  • Chorionic Gonadotropin / therapeutic use
  • Cryopreservation
  • Embryo Transfer / methods*
  • Female
  • Fertility Agents, Female / therapeutic use
  • Fertilization in Vitro / methods
  • Follicle Stimulating Hormone / therapeutic use
  • Humans
  • Ovulation Induction
  • Patient Acceptance of Health Care
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy Rate
  • Pregnancy, Multiple*

Substances

  • Chorionic Gonadotropin
  • Fertility Agents, Female
  • Follicle Stimulating Hormone
  • Buserelin